Syringe Services Programs to Reduce Intravenous Disease Transmission in Substance Use Disorders.

Nurs Clin North Am

Division of Public Health, Injury, and Violence Prevention Branch, North Carolina Department of Health and Human Services.

Published: June 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Syringe services programs (SSPs) are evidence-based programs. SSPs are integral in preventing bloodborne diseases while increasing access to care and reducing drug overdose deaths. SSPs are often the only source of health care for people who use drugs. Several states in the United States support and offer community-based SPPs; however, US prisons do not offer such programs to those incarcerated. Nurses are bridging the gap in support of SSPs and are being backed by organizations such as the American Nurses Association and the Association of Nurses in AIDS Care.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cnur.2023.01.004DOI Listing

Publication Analysis

Top Keywords

syringe services
8
services programs
8
programs ssps
8
programs
4
programs reduce
4
reduce intravenous
4
intravenous disease
4
disease transmission
4
transmission substance
4
substance disorders
4

Similar Publications

Objective To evaluate the effectiveness of ultrasound-guided marker placement in the precise localization of breast lesions, facilitate accurate surgical resection, and monitor tumor response during and after neoadjuvant chemotherapy. Materials and methods From January 2022 to December 2022, 70 female patients with breast carcinoma underwent a trial of metallic marker insertion into the tumor. The markers were made by cutting 5CC disposable syringe needles having a total length of 5 mm.

View Article and Find Full Text PDF

Stability and physical compatibility of parenteral nalbuphine hydrochloride during continuous infusion in pediatrics.

PLoS One

September 2025

Service Central de la Qualité et de l'Information Pharmaceutiques (SCQIP), Pharmacy Department, AP-HM, Hôpital de la Conception, Marseille, France.

In pediatric practice, nalbuphine hydrochloride can be administered by continuous infusion through a multiport manifold or Y-site connection over 24 h in a 60 mL polypropylene syringe unprotected from light at concentrations ranging from 52.1 µg.mL-1 to 333.

View Article and Find Full Text PDF

Background: HIV and Hepatitis C (HCV) are blood borne infections (BBIs) that remain a significant cause of global morbidity and mortality among people who inject drugs (PWID). UNAIDS and WHO have set goals for the elimination of viral hepatitis and HIV as major public health threats by 2030. To achieve these targets, innovative strategies are required among marginalized populations such as PWID, especially in resource-limited countries where coverage of harm reduction services is often limited.

View Article and Find Full Text PDF

A central challenge in the opioid crisis in the US has been the underuse of lifesaving treatment and harm reduction programs. Conventional explanations focus on limited access to care when services are not convenient, affordable, or timely. However, these factors exist downstream from other fundamental causes of low utilization.

View Article and Find Full Text PDF

Background: Fluid pH remains a standard test when evaluating pleural effusions. Studies recommend using a blood gas analyzer to measure fluid pH immediately after sample collection. Centralization of laboratory services at our institution led to migration of blood gas analysis to a single core laboratory with uncertain impacts on pH results.

View Article and Find Full Text PDF